NRG Awarded $500K by MJFF to Develop Disease-modifying Therapy

NRG Awarded $500K by MJFF to Develop Disease-modifying Therapy

301543

NRG Awarded $500K by MJFF to Develop Disease-modifying Therapy

NRG Therapeutics has been awarded a $500,000 grant by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support the development of its potential disease-modifying therapy for Parkinson’s. That funding will go toward investigating how small molecules, developed by NRG, inhibit the opening of mitochondrial pores, known as mPTP, and prevent dopamine-producing brain cells from dying — a process that is the hallmark of Parkinson’s disease. Mitochondria are the cellular organelles responsible for the…

You must be logged in to read/download the full post.